Wave Life Sciences GAAP EPS of -$0.30 misses by $0.03, revenue of $17.24M beats by $1.56M
Source: SeekingAlpha
2026-02-26 07:35:39 ET
More on Wave Life Sciences
- Wave Life Sciences: WVE-006 Now In Focus, Navigating Opportunity And Risk
- Wave Life Sciences Ltd. (WVE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Wave Life Sciences Ltd. (WVE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Wave Life Sciences Q4 2025 Earnings Preview
- Wave Life Sciences receives back rights to AATD therapy from GSK
Read the full article on Seeking Alpha
For further details see:
Wave Life Sciences GAAP EPS of -$0.30 misses by $0.03, revenue of $17.24M beats by $1.56M
Wave Life Sciences Ltd.
NASDAQ: WVE
WVE Trading
-4.68% G/L:
$13.25 Last:
962,987 Volume:
$13.79 Open:
WVE Latest News
March 05, 2026 08:30:00 am
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
February 26, 2026 07:30:00 am
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
WVE Stock Data
$2,455,817,603
74,781,401
10.3%
63
N/A
Biotechnology & Life Sciences
Healthcare
SG
